Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon.

Diazinon (DZN) is an organophosphorus pesticide with the possibility for widespread exposures. The toxicological effects of DZN are primarily mediated through the effects of its toxic metabolite, DZN-oxon on acetylcholinesterases, which results in accumulation of acetylcholine at neuronal junctions. A physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) model was developed to quantitatively assess the kinetics of DZN and its metabolites in blood and the inhibition of cholinesterases in plasma, RBC, brain, and diaphragm. Focused in vivo pharmacokinetic studies were conducted in male Sprague-Dawley rats and the data were used to refine the model. No overt toxicity was noted following doses up to 100mg/kg. However, cholinesterases in plasma, RBC, brain and diaphragm were substantially inhibited at doses of 50 mg/kg. In plasma, total cholinesterase was inhibited to less than 20% of control by 6 h post dosing with 100 mg/kg. Inhibition of brain acetylcholinesterase (AChE) following 100 mg/kg exposures was approximately 30% of control by 6 h. Diaphragm butyrylcholinesterase (BuChE) inhibition following 100 mg/kg dosing was to less than 20% of control by 6 h. The PBPK/PD model was used to describe the concentrations of DZN and its major, inactive metabolite, 2-isopropyl-4-methyl-6-hydroxypyrimidine (IMHP) in plasma and urinary elimination of IMHP. The fit of the model to plasma, RBC, brain, and diaphragm total cholinesterase and BuChE activity was also assessed and the model was further validated by fitting data from the open literature for intraperitoneal, intravenous, and oral exposures to DZN. The model was shown to quantitatively estimate target tissue dosimetry and cholinesterase inhibition following several routes of exposures. This model further confirms the usefulness of the model structure previously validated for chlorpyrifos and shows the potential utility of the model framework for other related organophosphate pesticides.

[1]  H. Maibach,et al.  Percutaneous absorption of diazinon in humans. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  L. R. Thompson,et al.  Validation of a whole blood method for cholinesterase monitoring. , 1983, American Industrial Hygiene Association Journal.

[3]  G. W. Jepson,et al.  Physiologically based modeling of nonsteady state dermal absorption of halogenated methanes from an aqueous solution. , 1997, Toxicology and applied pharmacology.

[4]  M E Andersen,et al.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.

[5]  J. Bakke,et al.  Rat urinary metabolites from O,O-diethyl-O-(3,5,6-trichloro-2-pyridyl) phosphorothioate. , 1976, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.

[6]  J. Cocker,et al.  Oral and dermal absorption of chlorpyrifos: a human volunteer study. , 1999, Occupational and environmental medicine.

[7]  T. Poet,et al.  In vitro rat hepatic and intestinal metabolism of the organophosphate pesticides chlorpyrifos and diazinon. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  K. Tomokuni,et al.  The tissue distribution of diazinon and the inhibition of blood cholinesterase activities in rats and mice receiving a single intraperitoneal dose of diazinon. , 1985, Toxicology.

[9]  B. P. Doctor,et al.  Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon. , 1998, Biochemical pharmacology.

[10]  M. Delp,et al.  Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.

[11]  S. Tsuda,et al.  Differences in the Mode of Lethality Produced through Intravenous and Oral Administration of Organophosphorus Insecticides in Rats , 1991 .

[12]  J. Chambers,et al.  Oxidative desulfuration of chlorpyrifos, chlorpyrifos-methyl, and leptophos by rat brain and liver. , 1989, Journal of biochemical toxicology.

[13]  Melvin E. Andersen,et al.  Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropyfluorophosphate , 1990 .

[14]  N. A. Shamaan,et al.  Insecticide metabolism by multiple glutathione S-transferases in two strains of the house fly, Musca domestica (L) , 1986 .

[15]  E. Hodgson,et al.  Metabolism in vitro of diazinon and diazoxon in rat liver. , 1971, Journal of agricultural and food chemistry.

[16]  R. Guy,et al.  Malathion percutaneous absorption after repeated administration to man. , 1983, Toxicology and applied pharmacology.

[17]  S. Barone,et al.  Ontogenetic differences in the regional and cellular acetylcholinesterase and butyrylcholinesterase activity in the rat brain. , 1998, Brain research. Developmental brain research.

[18]  K. Krishnan,et al.  A tissue composition-based algorithm for predicting tissue:air partition coefficients of organic chemicals. , 1996, Toxicology and applied pharmacology.

[19]  R. Carr,et al.  Acute effects of the organophosphate paraoxon on schedule-controlled behavior and esterase activity in rats: Dose-response relationships , 1991, Pharmacology Biochemistry and Behavior.

[20]  Olaf van Tellingen,et al.  The importance of drug-transporting P-glycoproteins in toxicology. , 2001 .

[21]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[22]  M. Hooper,et al.  Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos. , 1996, Journal of biochemical toxicology.

[23]  C Timchalk,et al.  Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model. , 2002, Toxicology letters.

[24]  A A Kousba,et al.  Characterization of the in vitro kinetic interaction of chlorpyrifos-oxon with rat salivary cholinesterase: a potential biomonitoring matrix. , 2003, Toxicology.

[25]  B. Heinzow,et al.  Pollutants in house dust as indicators of indoor contamination. , 2002, Reviews of environmental contamination and toxicology.

[26]  R. G. Lewis,et al.  Movement and Deposition of Two Organophosphorus Pesticides within a Residence after Interior and Exterior Applications , 2001, Journal of the Air & Waste Management Association.

[27]  J. Willems,et al.  Toxicokinetics of methyl parathion and parathion in the dog after intravenous and oral administration , 1983, Archives of Toxicology.

[28]  H. Maibach,et al.  Utility of real time breath analysis and physiologically based pharmacokinetic modeling to determine the percutaneous absorption of methyl chloroform in rats and humans. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  P. Taylor,et al.  Structural bases for the specificity of cholinesterase catalysis and inhibition. , 1995, Toxicology letters.

[30]  J. Descotes,et al.  Diazinon toxicokinetics, tissue distribution and anticholinesterase activity in the rat. , 1996, Biomedical and environmental sciences : BES.

[31]  Aldridge Wn.  The nature of the reaction of organophosphorus compounds and carbamates with esterases. , 1971 .

[32]  D. Rick,et al.  Chlorpyrifos: pharmacokinetics in human volunteers. , 1984, Toxicology and applied pharmacology.

[33]  C. Franklin.  Estimation of dermal exposure to pesticides and its use in risk assessment. , 1984, Canadian journal of physiology and pharmacology.

[34]  J. Chambers,et al.  Kinetic parameters of desulfuration and dearylation of parathion and chlorpyrifos by rat liver microsomes. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[35]  R L Fine,et al.  Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoprotein. , 1996, Journal of toxicology and environmental health.

[36]  K. Alt,et al.  Degradation of 14 C-labeled Diazinon in the rat. , 1970, Journal of agricultural and food chemistry.

[37]  E. Testai,et al.  Identification of the cytochrome P450 isoenzymes involved in the metabolism of diazinon in the rat liver , 1999, Journal of biochemical and molecular toxicology.

[38]  P. B. Ryan,et al.  Longitudinal investigation of dietary exposure to selected pesticides. , 2001, Environmental health perspectives.

[39]  C Timchalk,et al.  A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  Y. Ohno,et al.  Metabolism and Toxicity of Acid Phosphate Esters, Metabolites of Organophosphorous Insecticides, in Rat. , 1993 .

[41]  M E Andersen,et al.  Family approach for estimating reference concentrations/doses for series of related organic chemicals. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  J. Cocker,et al.  Exposure to the organophosphate diazinon: data from a human volunteer study with oral and dermal doses. , 2002, Toxicology letters.

[43]  J. Fisher,et al.  Gastrointestinal absorption of xenobiotics in physiologically based pharmacokinetic models. A two-compartment description. , 1991, Drug metabolism and disposition: the biological fate of chemicals.